{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T02:46:20Z","timestamp":1783478780959,"version":"3.55.0"},"reference-count":32,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cytokine"],"published-print":{"date-parts":[[2023,10]]},"DOI":"10.1016\/j.cyto.2023.156318","type":"journal-article","created":{"date-parts":[[2023,8,5]],"date-time":"2023-08-05T21:46:42Z","timestamp":1691272002000},"page":"156318","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Insight to the association among fibroblast growth factor 21, non-alcoholic fatty liver disease and cardiovascular outcomes: A population-based study"],"prefix":"10.1016","volume":"170","author":[{"given":"Yun","family":"Shen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tingting","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongyu","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiting","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yufei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaojing","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuqian","family":"Bao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cyto.2023.156318_b0005","doi-asserted-by":"crossref","first-page":"2537","DOI":"10.1016\/j.cell.2021.04.015","article-title":"Mechanisms and disease consequences of nonalcoholic fatty liver disease","volume":"184","author":"Loomba","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.cyto.2023.156318_b0010","doi-asserted-by":"crossref","first-page":"e574","DOI":"10.1212\/WNL.0000000000200853","article-title":"Nonalcoholic fatty liver disease and risk of dementia: A population-based cohort study","volume":"99","author":"Shang","year":"2022","journal-title":"Neurology"},{"issue":"Suppl 1","key":"10.1016\/j.cyto.2023.156318_b0015","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1111\/liv.14362","article-title":"Natural history of NASH and HCC","volume":"40","author":"Negro","year":"2020","journal-title":"Liver Int."},{"key":"10.1016\/j.cyto.2023.156318_b0020","first-page":"194","article-title":"Pathophysiological mechanisms of cardiovascular disorders in non-alcoholic fatty liver disease","volume":"15","author":"Garbuzenko","year":"2022","journal-title":"Gastroenterol. Hepatol. Bed. Bench."},{"key":"10.1016\/j.cyto.2023.156318_b0025","doi-asserted-by":"crossref","first-page":"5928","DOI":"10.7150\/ijbs.76924","article-title":"Hepatic FGF21: Its emerging role in inter-organ crosstalk and cancers","volume":"18","author":"Sui","year":"2022","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.cyto.2023.156318_b0030","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1186\/1475-2840-12-124","article-title":"Additive relationship between serum fibroblast growth factor 21 level and coronary artery disease","volume":"12","author":"Shen","year":"2013","journal-title":"Cardiovasc. Diabetol."},{"key":"10.1016\/j.cyto.2023.156318_b0035","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1159\/000486127","article-title":"Serum FGF21 Is associated with future cardiovascular events in patients with coronary artery disease","volume":"139","author":"Shen","year":"2018","journal-title":"Cardiology"},{"key":"10.1016\/j.cyto.2023.156318_b0040","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1186\/s12933-017-0588-5","article-title":"Contribution of serum FGF21 level to the identification of left ventricular systolic dysfunction and cardiac death","volume":"16","author":"Shen","year":"2017","journal-title":"Cardiovasc. Diabetol."},{"key":"10.1016\/j.cyto.2023.156318_b0045","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1016\/S0140-6736(19)30427-1","article-title":"Mortality, morbidity, and risk factors in China and its provinces, 1990\u20132017: A systematic analysis for the global burden of disease study 2017","volume":"394","author":"Zhou","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.cyto.2023.156318_b0050","doi-asserted-by":"crossref","first-page":"2830","DOI":"10.1016\/j.numecd.2022.08.023","article-title":"Neck circumference for predicting the occurrence of future cardiovascular events: A 7.6-year longitudinal study","volume":"32","author":"Hu","year":"2022","journal-title":"Nutr. Metab. Cardiovasc. Dis."},{"key":"10.1016\/j.cyto.2023.156318_b0055","doi-asserted-by":"crossref","first-page":"4135","DOI":"10.2147\/DMSO.S328206","article-title":"Serum fibroblast growth factor 23 level and liver fat content in MAFLD: A community-based cohort","volume":"14","author":"Cao","year":"2021","journal-title":"Diabetes. Metab. Syndr. Obes."},{"key":"10.1016\/j.cyto.2023.156318_b0060","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1007\/BF00280883","article-title":"Homeostasis model assessment: Insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man","volume":"28","author":"Matthews","year":"1985","journal-title":"Diabetologia"},{"key":"10.1016\/j.cyto.2023.156318_b0065","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1177\/0163278718819708","article-title":"Validity of the international physical activity questionnaire-short form for application in asian countries: A study in vietnam","volume":"43","author":"Tran","year":"2020","journal-title":"Eval. Health Prof."},{"key":"10.1016\/j.cyto.2023.156318_b0070","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S2213-8587(19)30425-5","article-title":"Association of insulin resistance and \u03b2-cell dysfunction with incident diabetes among adults in China: A nationwide, population-based, prospective cohort study","volume":"8","author":"Wang","year":"2020","journal-title":"Lancet. Diabetes. Endocrinol."},{"key":"10.1016\/j.cyto.2023.156318_b0075","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1001\/jama.282.13.1247","article-title":"Smoking in China: Findings of the 1996 National Prevalence Survey","volume":"282","author":"Yang","year":"1999","journal-title":"J. Am. Med. Assoc."},{"issue":"2020","key":"10.1016\/j.cyto.2023.156318_b0080","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1161\/HYPERTENSIONAHA.120.15026","article-title":"International Society of Hypertension Global Hypertension Practice Guidelines","volume":"75","author":"Unger","year":"2020","journal-title":"Hypertension"},{"key":"10.1016\/j.cyto.2023.156318_b0085","doi-asserted-by":"crossref","unstructured":"American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes. Care. 33 Suppl 1 (2010) S62-S69.","DOI":"10.2337\/dc10-S062"},{"key":"10.1016\/j.cyto.2023.156318_b0090","unstructured":"Joint committee for guideline revision. 2016 Chinese guidelines for the management of dyslipidemia in adults. J. Geriatr. Cardiol. 15 (2018) 1-29."},{"key":"10.1016\/j.cyto.2023.156318_b0095","doi-asserted-by":"crossref","unstructured":"European Association for the Study of the Liver (EASL) EAftSoDE, European Association for the Study of Obesity (EASO), EASL-EASD-EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease. J. Hepatol. 64 (2016) 1388-1402.","DOI":"10.1016\/j.jhep.2015.11.004"},{"key":"10.1016\/j.cyto.2023.156318_b0100","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1002\/hep.21496","article-title":"The NAFLD fibrosis score: A noninvasive system that identifies liver fibrosis in patients with NAFLD","volume":"45","author":"Angulo","year":"2007","journal-title":"Hepatology"},{"key":"10.1016\/j.cyto.2023.156318_b0105","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1136\/jech.55.7.508","article-title":"A heuristic approach to the formulas for population attributable fraction","volume":"55","author":"Hanley","year":"2001","journal-title":"J. Epidemiol. Community. Health."},{"key":"10.1016\/j.cyto.2023.156318_b0110","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1053\/j.gastro.2005.04.014","article-title":"The natural history of nonalcoholic fatty liver disease: A population-based cohort study","volume":"129","author":"Adams","year":"2005","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cyto.2023.156318_b0115","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1210\/clinem\/dgab641","article-title":"Association of MAFLD With diabetes, chronic kidney disease, and cardiovascular disease: A 4.6-year cohort study in china","volume":"107","author":"Liang","year":"2022","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.cyto.2023.156318_b0120","doi-asserted-by":"crossref","first-page":"101138","DOI":"10.1016\/j.molmet.2020.101138","article-title":"Hepatokines and metabolism: Deciphering communication from the liver","volume":"44","author":"Jensen-Cody","year":"2021","journal-title":"Mol. Metab."},{"key":"10.1016\/j.cyto.2023.156318_b0125","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1016\/j.jhep.2010.05.018","article-title":"Fibroblast growth factor 21 levels are increased in nonalcoholic fatty liver disease patients and are correlated with hepatic triglyceride","volume":"53","author":"Li","year":"2010","journal-title":"J. Hepatol."},{"issue":"3","key":"10.1016\/j.cyto.2023.156318_b0130","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/j.jhep.2012.10.029","article-title":"High serum level of fibroblast growth factor 21 is an independent predictor of non-alcoholic fatty liver disease: A 3-year prospective study in China","volume":"58","author":"Li","year":"2013","journal-title":"J. Hepatol."},{"key":"10.1016\/j.cyto.2023.156318_b0135","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1007\/s13105-019-00675-7","article-title":"FGF19 subfamily members: FGF19 and FGF21","volume":"75","author":"Dolegowska","year":"2019","journal-title":"J. Physiol. Biochem."},{"key":"10.1016\/j.cyto.2023.156318_b0140","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/s12933-015-0190-7","article-title":"Serum fibroblast growth factor 21 levels is associated with lower extremity atherosclerotic disease in Chinese female diabetic patients","volume":"14","author":"Zhang","year":"2015","journal-title":"Cardiovasc. Diabetol."},{"key":"10.1016\/j.cyto.2023.156318_b0145","doi-asserted-by":"crossref","first-page":"e015226","DOI":"10.1161\/JAHA.119.015226","article-title":"Fibroblast growth factor 21 is related to atherosclerosis independent of nonalcoholic fatty liver disease and predicts atherosclerotic cardiovascular events","volume":"9","author":"Wu","year":"2020","journal-title":"J. Am. Heart Assoc."},{"key":"10.1016\/j.cyto.2023.156318_b0150","first-page":"3417","article-title":"Fibroblast growth factor 21 as a possible endogenous factor inhibits apoptosis in cardiac endothelial cells","volume":"123","author":"L\u00fc","year":"2010","journal-title":"Chin. Med. J (Engl)."},{"key":"10.1016\/j.cyto.2023.156318_b0155","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/j.cmet.2013.04.005","article-title":"Adiponectin mediates the metabolic effects of FGF21 on glucose homeostasis and insulin sensitivity in mice","volume":"17","author":"Lin","year":"2013","journal-title":"Cell. Metab."},{"key":"10.1016\/j.cyto.2023.156318_b0160","doi-asserted-by":"crossref","first-page":"2781","DOI":"10.2337\/db10-0193","article-title":"Obesity is a fibroblast growth factor 21 (FGF21)-resistant state","volume":"59","author":"Fisher","year":"2010","journal-title":"Diabetes"}],"container-title":["Cytokine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043466623001965?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043466623001965?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,9]],"date-time":"2025-01-09T10:05:47Z","timestamp":1736417147000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043466623001965"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10]]},"references-count":32,"alternative-id":["S1043466623001965"],"URL":"https:\/\/doi.org\/10.1016\/j.cyto.2023.156318","relation":{},"ISSN":["1043-4666"],"issn-type":[{"value":"1043-4666","type":"print"}],"subject":[],"published":{"date-parts":[[2023,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Insight to the association among fibroblast growth factor 21, non-alcoholic fatty liver disease and cardiovascular outcomes: A population-based study","name":"articletitle","label":"Article Title"},{"value":"Cytokine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cyto.2023.156318","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"156318"}}